Targeting NAMPT offers a promising therapeutic strategy for modulating fibroblast behavior, reducing fibrosis, and disrupting the pro-fibrotic cell communication network in IPF. This evidence concerns the gene NAMPT and idiopathic pulmonary fibrosis.